Abaxis management shuffle
This article was originally published in The Gray Sheet
Firm names President and CEO Clint Severson as chairman of the board, replacing Abaxis co-founder Gary Stroy. Severson has been key to increasing revenue while reducing operational costs for the past seven quarters, the company says. Jim Canfield, former VP-marketing and sales at competitor Idexx Laboratories, joins Abaxis as VP-domestic marketing. Canfield replaces Vladimir Ostoich, who returns to his original position as VP-engineering. Chief Financial Officer and VP-finance Ting Lu is stepping down at the end of the month and will be replaced in the interim by Controller Reba Witwer. Other new appointments include Robert Milder as VP-operations; Larry Reynolds (VP-marketing and sales, Pacific Rim and Latin America) and Diane Oates (VP-regulatory affairs/quality systems)...
You may also be interested in...
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.